Selected research
Industry Research
Pharmaceutical Contract Service Outsourcing Industry Research Report 2026
Market perspective
The global Pharmaceutical Contract Service Outsourcing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Contract Service Outsourcing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Contract Service Outsourcing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Contract Service Outsourcing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Contract Service Outsourcing include Charles River, IQVIA, Lonza, PPD, ICON Plc, Inotiv, Labcorp, Eurofins Scientific and JOINN Lab, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Contract Service Outsourcing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Contract Service Outsourcing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Contract Service Outsourcing Market by Company
Charles River
IQVIA
Lonza
PPD
ICON Plc
Inotiv
Labcorp
Eurofins Scientific
JOINN Lab
EVOTEC
EVERSANA
Amplity Health
Tigermed
ChemPartner
Medicilon
WuXi AppTec
China Medical System
Sinco Pharma
Pharmaceutical Contract Service Outsourcing Segment by Type
CRO
CMO
CDMO
CSO
Pharmaceutical Contract Service Outsourcing Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
Pharmaceutical Contract Service Outsourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Service Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Service Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Service Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Contract Service Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CRO
- CMO
- CDMO
- CSO
Applications
- Pharmaceutical Company
- Biotechnology Company
- Others
Companies covered
- Charles River
- IQVIA
- Lonza
- PPD
- ICON Plc
- Inotiv
- Labcorp
- Eurofins Scientific
- JOINN Lab
- EVOTEC
- EVERSANA
- Amplity Health
- Tigermed
- ChemPartner
- Medicilon
- WuXi AppTec
- China Medical System
- Sinco Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Contract Service Outsourcing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 CRO
- 2.2.3 CMO
- 2.2.4 CDMO
- 2.2.5 CSO
- 2.3 Pharmaceutical Contract Service Outsourcing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Company
- 2.3.3 Biotechnology Company
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Pharmaceutical Contract Service Outsourcing Breakdown Data by Type
- 3.1 Global Pharmaceutical Contract Service Outsourcing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Contract Service Outsourcing Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Contract Service Outsourcing Breakdown Data by Application
- 4.1 Global Pharmaceutical Contract Service Outsourcing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Contract Service Outsourcing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Contract Service Outsourcing Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Contract Service Outsourcing Growth Trends by Region
- 5.2.1 Global Pharmaceutical Contract Service Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Contract Service Outsourcing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Contract Service Outsourcing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Contract Service Outsourcing Market Dynamics
- 5.3.1 Pharmaceutical Contract Service Outsourcing Industry Trends
- 5.3.2 Pharmaceutical Contract Service Outsourcing Market Drivers
- 5.3.3 Pharmaceutical Contract Service Outsourcing Market Challenges
- 5.3.4 Pharmaceutical Contract Service Outsourcing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Contract Service Outsourcing Players by Revenue
- 6.1.1 Global Top Pharmaceutical Contract Service Outsourcing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Contract Service Outsourcing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Contract Service Outsourcing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Contract Service Outsourcing Head Office and Area Served
- 6.4 Global Pharmaceutical Contract Service Outsourcing Players, Product Type & Application
- 6.5 Global Pharmaceutical Contract Service Outsourcing Manufacturers Established Date
- 6.6 Global Pharmaceutical Contract Service Outsourcing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Contract Service Outsourcing Market Size (2021-2032)
- 7.2 North America Pharmaceutical Contract Service Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Contract Service Outsourcing Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Contract Service Outsourcing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Contract Service Outsourcing Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Contract Service Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Contract Service Outsourcing Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Contract Service Outsourcing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Contract Service Outsourcing Market Size (2021-2032)
- 10.2 South America Pharmaceutical Contract Service Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Contract Service Outsourcing Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Contract Service Outsourcing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Contract Service Outsourcing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Contract Service Outsourcing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Contract Service Outsourcing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Contract Service Outsourcing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River
- 12.1.1 Charles River Company Information
- 12.1.2 Charles River Business Overview
- 12.1.3 Charles River Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.1.4 Charles River Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.1.5 Charles River Recent Developments
- 12.2 IQVIA
- 12.2.1 IQVIA Company Information
- 12.2.2 IQVIA Business Overview
- 12.2.3 IQVIA Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.2.4 IQVIA Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.2.5 IQVIA Recent Developments
- 12.3 Lonza
- 12.3.1 Lonza Company Information
- 12.3.2 Lonza Business Overview
- 12.3.3 Lonza Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.3.4 Lonza Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.3.5 Lonza Recent Developments
- 12.4 PPD
- 12.4.1 PPD Company Information
- 12.4.2 PPD Business Overview
- 12.4.3 PPD Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.4.4 PPD Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.4.5 PPD Recent Developments
- 12.5 ICON Plc
- 12.5.1 ICON Plc Company Information
- 12.5.2 ICON Plc Business Overview
- 12.5.3 ICON Plc Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.5.4 ICON Plc Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.5.5 ICON Plc Recent Developments
- 12.6 Inotiv
- 12.6.1 Inotiv Company Information
- 12.6.2 Inotiv Business Overview
- 12.6.3 Inotiv Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.6.4 Inotiv Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.6.5 Inotiv Recent Developments
- 12.7 Labcorp
- 12.7.1 Labcorp Company Information
- 12.7.2 Labcorp Business Overview
- 12.7.3 Labcorp Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.7.4 Labcorp Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.7.5 Labcorp Recent Developments
- 12.8 Eurofins Scientific
- 12.8.1 Eurofins Scientific Company Information
- 12.8.2 Eurofins Scientific Business Overview
- 12.8.3 Eurofins Scientific Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.8.4 Eurofins Scientific Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.8.5 Eurofins Scientific Recent Developments
- 12.9 JOINN Lab
- 12.9.1 JOINN Lab Company Information
- 12.9.2 JOINN Lab Business Overview
- 12.9.3 JOINN Lab Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.9.4 JOINN Lab Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.9.5 JOINN Lab Recent Developments
- 12.10 EVOTEC
- 12.10.1 EVOTEC Company Information
- 12.10.2 EVOTEC Business Overview
- 12.10.3 EVOTEC Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.10.4 EVOTEC Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.10.5 EVOTEC Recent Developments
- 12.11 EVERSANA
- 12.11.1 EVERSANA Company Information
- 12.11.2 EVERSANA Business Overview
- 12.11.3 EVERSANA Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.11.4 EVERSANA Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.11.5 EVERSANA Recent Developments
- 12.12 Amplity Health
- 12.12.1 Amplity Health Company Information
- 12.12.2 Amplity Health Business Overview
- 12.12.3 Amplity Health Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.12.4 Amplity Health Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.12.5 Amplity Health Recent Developments
- 12.13 Tigermed
- 12.13.1 Tigermed Company Information
- 12.13.2 Tigermed Business Overview
- 12.13.3 Tigermed Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.13.4 Tigermed Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.13.5 Tigermed Recent Developments
- 12.14 ChemPartner
- 12.14.1 ChemPartner Company Information
- 12.14.2 ChemPartner Business Overview
- 12.14.3 ChemPartner Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.14.4 ChemPartner Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.14.5 ChemPartner Recent Developments
- 12.15 Medicilon
- 12.15.1 Medicilon Company Information
- 12.15.2 Medicilon Business Overview
- 12.15.3 Medicilon Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.15.4 Medicilon Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.15.5 Medicilon Recent Developments
- 12.16 WuXi AppTec
- 12.16.1 WuXi AppTec Company Information
- 12.16.2 WuXi AppTec Business Overview
- 12.16.3 WuXi AppTec Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.16.4 WuXi AppTec Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.16.5 WuXi AppTec Recent Developments
- 12.17 China Medical System
- 12.17.1 China Medical System Company Information
- 12.17.2 China Medical System Business Overview
- 12.17.3 China Medical System Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.17.4 China Medical System Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.17.5 China Medical System Recent Developments
- 12.18 Sinco Pharma
- 12.18.1 Sinco Pharma Company Information
- 12.18.2 Sinco Pharma Business Overview
- 12.18.3 Sinco Pharma Revenue in Pharmaceutical Contract Service Outsourcing Business (2021-2026)
- 12.18.4 Sinco Pharma Pharmaceutical Contract Service Outsourcing Product Portfolio
- 12.18.5 Sinco Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst